Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates
about
Management of antithrombotic therapy during cardiac implantable device surgerySafety of new oral anticoagulant drugs: a perspectiveEfficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis.Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolismUpdate in perioperative medicine: practice-changing evidence published in 2015.The Reversal of Direct Oral Anticoagulants in Animal Models.The Canadian Choosing Wisely campaign: the Canadian Hematology Society's top five tests and treatments.The Perioperative Management of Antithrombotic Therapies Using Enoxaparin.Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 scoreManagement of non-vitamin K antagonist oral anticoagulants in the perioperative settingOutcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o"Tiers of delay": warfarin, hip fractures, and target-driven care.Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).Thromboprophylaxis and bleeding diathesis in minimally invasive stone surgery.Risk of complications due to anticoagulation during dermatosurgical procedures: a systematic review and meta-analysis.Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.Dental Procedures in Patients with Atrial Fibrillation and New Oral Anticoagulants.Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillationPURLs: Should you bypass anticoagulant "bridging" before and after surgery?Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.The perioperative management of treatment with anticoagulants and platelet aggregation inhibitors.Left Atrial Appendage Thrombus Resolution with Reduced Dose Apixaban.Heparin bridge therapy and post-polypectomy bleedingClinical problems with antithrombotic therapy for endoscopic submucosal dissection for gastric neoplasms.Short-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient CareThromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplastiesSafety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.The future of inpatient anticoagulation management.The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation.Perioperative management of anticoagulation in elective surgery.Perioperative management of patients who are receiving a novel oral anticoagulant.Update in perioperative medicine 2013.The current status of bridging anticoagulation.Management of peri-operative anti-thrombotic therapy.Blood transfusion practices in neuroanaesthesiaPeriprocedural management of rivaroxaban-treated patients.Management of antithrombotic therapy in patients undergoing electrophysiological device surgery.Prevention of gastrointestinal events in patients on antithrombotic therapy in the peri-endoscopy period: review of new evidence and recommendations from recent guidelines.Perioperative Management of Antithrombotic Therapy in Common Otolaryngologic Surgical Procedures: State of the Art Review.
P2860
Q26746160-BBD259B6-E9D5-42D5-A5FD-4F6FD6761849Q27016072-9E156D15-9C0C-42EB-BD4F-4CF2D007AB8CQ27690881-439D7E03-6792-4F43-9126-651B5A9E61D8Q28066527-22053EF5-76AF-41B6-9DFF-A43AB6FFE4E1Q30249060-03DB26A8-A19D-486A-8BAC-D34099D58249Q30491580-9BDF6EBE-0AF5-4486-8179-FD787C869B42Q33420089-AC1A5331-719C-408B-9137-04517A659790Q33661487-D4CF418B-907F-4C1C-9472-6F6288A26C3BQ33685880-FE4BC514-00E4-4A34-B6F6-CE05174571E0Q34207558-6C7C9D1F-2FE7-41C6-A30B-38A012CBBEFBQ34388837-7541C577-4161-49EA-9A86-3CBB3596E6C5Q34418557-01C16782-E86B-4501-8870-8A3B37FBA05BQ34683960-A9184BE3-6249-4228-A0A9-8C446C6A700AQ35044476-29059708-2E48-41E6-B13D-EBBE652C6FDDQ35068889-E294F8B4-6C02-4309-9483-C0E438D22C88Q35226789-122B3E4F-CDF4-43E7-8DC6-5C3C7B0F720FQ35262940-719E861A-DF3D-4270-BCAC-C18093DA2120Q36458951-64E062F0-3FA4-4D1D-BB0A-6F0C04A49A73Q36673613-6CD06A0B-8325-4267-9226-4584D6C64991Q36862109-459A0726-BB66-4B69-8A63-A638EAF2BA47Q37062044-34B61483-5EA5-4E34-815B-74ED3328A1F2Q37194881-3AD14AD6-7ED3-4964-9DC6-01390284EAAEQ37468780-3501B602-5A5D-4389-A50F-87B1C3DD6919Q37483431-5A5E68CB-9B27-49F0-8231-6C4CC2D04F80Q37507967-8841C850-50FD-4083-8203-123D98BDBB66Q37556151-573C3FD3-D43B-4117-8B96-1F9B29843DE6Q37597171-BAF026C7-0653-4E0A-B011-019F44A872BFQ37723884-A4C8F940-1420-47D1-94EE-2C7550FDBF79Q38082467-3AA2534D-9AEA-4173-8FFA-04B1565355AEQ38097972-356D788D-F6CD-441D-881B-BBF46FEDA950Q38100294-C133E8C0-B919-44F0-B7DD-87FA00081A08Q38117546-617334A5-2DF4-4CE4-9D55-9B903C9A7C75Q38154446-439E2842-71F3-49C2-AAC9-55E9EDBA3975Q38162274-FE3FD87F-40DF-428B-88FD-038E31F94BBEQ38273789-B040BBF0-2637-4679-ABC2-ECB6E3851EB0Q38298655-22A1230D-8FF0-46CE-8082-A496D39A6706Q38358851-21F0C7B1-96CF-4291-9A22-7D588AE0D8F9Q38364982-362AC677-15FE-47B7-9E5B-C749C87E65E4Q38394833-C1D4C309-F013-446A-915E-0E9819356C89Q38573932-75476A11-AD6B-479F-AB10-621790426DD3
P2860
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@ast
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@en
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@nl
type
label
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@ast
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@en
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@nl
prefLabel
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@ast
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@en
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@nl
P2093
P31
P921
P1433
P1476
Periprocedural heparin bridgin ...... eding and thromboembolic rates
@en
P2093
Alex C Spyropoulos
James D Douketis
Jovana Yudin
Scott Kaatz
P304
P356
10.1161/CIRCULATIONAHA.112.105221
P407
P577
2012-08-21T00:00:00Z